Yucca Health vs Willow: Compounded GLP-1 vs Oral Program Compared
Quick verdict: Yucca Health focuses on low-cost compounded semaglutide and tirzepatide with fast 24-hour approvals and UPS 2-Day Air shipping, while Willow centers on an oral GLP-1 program that emphasizes progress tracking and follow-up support.
See Yucca Health semaglutide and tirzepatide plans
Yucca Health vs Willow: primary differences at a glance
This comparison focuses on five supported differences: starting price, medication format and options, clinical workflow and approval timing, follow-up and progress tracking, and regulatory notes. The introduction above gives the early verdict and the rest of the article compares features directly.
1) Price and plan types
Yucca Health lists compounded semaglutide starting at $146/month and compounded tirzepatide starting at $258/month, with a 6-month semaglutide plan available. Willow shows a higher monthly entry price listed as $299. These figures reflect the captured pricing details for each provider.
Explore Willow’s oral GLP-1 program
2) Medication format and options
Yucca Health offers compounded injectable semaglutide and compounded tirzepatide, and highlights tirzepatide as a dual GIP/GLP-1 option. Willow is described as an oral GLP-1 program. Where Yucca provides both semaglutide and tirzepatide choices, Willow emphasizes an oral medication pathway paired with program support.
3) Clinical workflow and shipping speed
Yucca Health describes an online intake that takes about 10 minutes, licensed provider review typically within 24 hours, prescription fulfillment at licensed U.S. compounding pharmacies, and UPS 2-Day Air shipping with most patients receiving first shipment within 3 to 5 business days. Willow is presented as telehealth-first with a simple digital workflow, but captured pages did not verify specific approval or shipping timelines.
4) Follow-up, tracking, and program structure
Willow positions its offering as a structured weight management journey with progress tracking tools and follow-up consultations, framed for users who want behavioral support alongside medication. Yucca Health emphasizes personalized treatment plans and online provider support for dosage adjustments, but the captured evidence highlights direct-pay pricing, BNPL options, and ongoing provider support rather than an explicit structured tracking program.
Review Yucca Health treatment features
5) Regulatory notes and insurance
Both providers include qualifications about medication availability: Yucca Health offers compounded medications and the captured content states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Yucca Health does not accept health insurance and offers Buy Now Pay Later options (Klarna, Afterpay, Affirm). Willow’s captured content notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. No insurance acceptance details for Willow were captured.
Comparison table: Yucca Health vs Willow
| Criteria | Yucca Health | Willow |
|---|---|---|
| Starting price | Semaglutide from $146/mo; Tirzepatide from $258/mo | $299 (monthly entry listed) |
| Medication format | Compounded injectable semaglutide and tirzepatide | Oral GLP-1 program |
| Approval and shipping | Online intake ~10 minutes; decision often within 24 hours; UPS 2-Day Air | Telehealth-first workflow; specific timelines not verified |
| Follow-up and tracking | Ongoing provider support and dosage adjustments | Progress tracking tools and follow-up consultations emphasized |
| Regulatory note | Compounded meds not FDA-approved; not reviewed by FDA for safety, effectiveness or quality | Medication-specific approval status must be confirmed; branded and compounded products not interchangeable |
How each provider positions itself
Yucca Health positions TryYucca as an accessible compounded GLP-1 telehealth platform that highlights low starting prices, fast approvals, licensed providers in all 50 states, and multiple BNPL payment options. Willow positions its oral GLP-1 program as a structured journey with progress tracking and follow-up to convert medication effects into sustained outcomes.
Learn more about Willow’s program
Conclusion: Yucca Health vs Willow
Yucca Health is centered on lower-cost compounded injectable semaglutide and tirzepatide with fast online approval and UPS 2-Day Air shipping. Willow focuses on an oral GLP-1 program with progress tracking and follow-up consultations. Choose based only on the captured evidence of price, medication format, workflow, and support emphasis.
Choose Yucca Health if you want lower starting prices for compounded semaglutide or tirzepatide, fast online approval, and UPS 2-Day Air shipping.
Choose Willow if you prefer an oral GLP-1 pathway with structured progress tracking and follow-up consultations.